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Type D Personality Is Associated With Increased Anxiety and Depressive
Symptoms in Patients With an Implantable Cardioverter Defibrillator and
Their Partners
SUSANNE S. PEDERSEN, PHD, RON T. VAN DOMBURG, PHD, DOMINIC A. M. J. THEUNS, MSC, LUC JORDAENS, MD, PHD,
AND RUUD A. M. ERDMAN, PHD
Objective: We investigated the prevalence of anxiety and depressive symptoms in patients with an implantable cardioverter
defibrillator (ICD) and their partners, and the role of personality factors and social support as determinants of distress. Methods:
Of all surviving patients (n  221) having had an ICD implanted between October 1998 and January 2003, 182 patients and 144
partners completed the Hospital Anxiety and Depression Scale, the Type D Personality Scale, and the Perceived Social Support
Scale. Type D personality defines those who tend to experience increased negative distress and who do not express these negative
emotions in social interactions. Clinical variables for the patients were obtained from medical records. Results: Thirty-one percent
of patients versus 42% of partners suffered from symptoms of anxiety (p  .048); symptoms of anxiety were particularly prevalent
in male partners. Twenty-eight vs. 29% suffered from depressive symptoms (p  .901). In patients, Type D personality was
independently related to anxiety (OR: 7.03; 95% CI: 2.32–21.32) and depressive symptoms (OR: 7.40; 95% CI: 2.49–21.94)
adjusting for all other variables. Underlying cardiac disease pathology did not explain differences in patient distress. In partners,
Type D personality was independently associated with increased symptoms of anxiety (OR: 8.77; 95% CI: 3.19–24.14) and
depression (OR: 4.40; 95% CI: 1.76–11.01). Conclusion: Partners experienced similar levels of depression but higher levels of
anxiety compared with ICD patients. Personality was an important explanatory factor of distress in both ICD patients and their
partners. Research is now warranted to investigate the implications of this finding for the clinical course of ICD patients, as Type
D personality has been associated with adverse prognosis in patients with coronary artery disease. Key words: anxiety, coronary
artery disease, depressive symptoms, implantable cardioverter defibrillator, Type D personality.
CAD  coronary artery disease; ICD  implantable cardioverter
defibrillator; MI  myocardial infarction.
INTRODUCTION
Indications for and clinical application of the implantablecardioverter defibrillator (ICD) have expanded since the
introduction of the device to prevent sudden cardiac death in
patients with ventricular arrhythmias, and current guidelines
now also advocate prophylactic use (1,2). The medical bene-
fits of the ICD are unequivocal, but living with an ICD may
adversely affect psychosocial functioning and the quality of
life of a subgroup of patients and their partners (3–6). In turn,
psychological mood states, such as anxiety and anger, have
been shown to precipitate arrhythmic events in ICD patients
(7,8). Identification of determinants of psychological distress
in patients and their partners is therefore crucial for the man-
agement of distress and the improvement of quality of life,
health, and clinical outcomes.
Number of ICD discharges deemed as inappropriate by the
patient, shocks, diminished physical activity, younger age, and
clinical variables (eg, lower ejection fraction, prior myocardial
infarction (MI), and higher NYHA class) have been identified
as determinants of psychological distress in ICD patients
(9–11). In partners, the use of psychotropic medication and
emotion-focused coping have been associated with more dis-
tress, and the use of challenge appraisal with less distress (4).
Partners of patients who have experienced shocks or who have
had a prior MI have also been shown to report more distress
(10,11).
To our knowledge, no studies have investigated the role
of personality and social support as determinants of distress
in ICD patients and their partners. Personality factors may
have much explanatory power of differences in outcome, as
indicated by recent research on Type D personality—also
called the distressed personality. Type D is a taxonomy
based on the two stable personality traits of negative affec-
tivity and social inhibition and denotes those individuals
who experience increased negative distress and who do not
express these negative emotions in social interactions (12).
Type D personality has been associated with a variety of
emotional and social difficulties, and increased morbidity
and mortality in patients with established heart disease
(12–15). A recent study of patients with a first myocardial
infarction also showed that personality factors may mediate
the buffering effect of social support on psychological
distress (16).
Little is also known about the distress levels of partners
compared with ICD patients. Previous studies have been based
on relative small sample sizes (10,17,18) or only focused on
the reactions of family members (4). Partners may experience
as much distress as patients, as evidenced in a study of cancer
patients and their partners (19). Increased distress in partners
would have important clinical implications and may indicate
whether psychosocial programs should also be extended to
partners of ICD patients.
The objectives of the current study were a) to investigate
the prevalence of anxiety and depressive symptoms in ICD
patients and their partners, and b) to examine the role of Type
D personality and social support as determinants of distress in
ICD patients and their partners.
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METHODS
Study Population
All surviving patients (n  225) having had an ICD implanted at the
Erasmus Medical Center Rotterdam between October 1998 and January 2003
and their partners were asked as part of routine clinical practice to fill in a
number of questionnaires to assess their psychological health. Four patients
were excluded due to terminal illness, brain damage, age below 16 years, or
too many missing values on questionnaires. Of the remaining 221 patients,
182 (82%) participated together with 144 partners.
Measures
Clinical Variables
Information on time since implantation (in months), coronary artery disease
(CAD), chronic heart failure, previous MI, previous bypass surgery, previous
cardiac arrest, the use of antiarrhythmic drugs at baseline, and shocks (no shocks
vs. 1 shock) were obtained from the medical records of the patients.
Psychological Variables
We used the Hospital Anxiety and Depression Scale (HADS) to measure
symptoms of anxiety and depression (20). The scale consists of 14 items that are
answered on a four-point Likert scale (0–3). The score range for both the anxiety
and depression subscales is 0 to 21. The HADS has been validated in the general
population, somatic, psychiatric, and cardiac patients, and has been shown to be
a valid and reliable instrument with Cronbach’s alpha ranging from 0.67 to 0.93
for the two subscales (20–23). We used a score of 8 to determine caseness on
both subscales, as a recent review has suggested that this cut-off score yields an
optimal balance between sensitivity and specificity (22).
The 14-item Type D Personality Scale (DS14) assessing negative affec-
tivity (eg, “I often feel unhappy”) and social inhibition (eg, “I am a closed
kind of person”) was included to assess the potential role of Type D as a
determinant of anxiety and depression (24). The 14 items are answered on a
5-point Likert scale: (0  false), (1  mostly false), (2  neutral), (3 
mostly true), (4  true). Those scoring high on both subscales according to a
cut-off 10 are categorized as Type D. The reliability of both subscales is
adequate with Cronbach’s   0.88 and   0.86 for the negative affectivity
and social inhibition subscales, respectively (24).
The Perceived Social Support Scale (PSSS) was included to evaluate the role
of social support as a determinant of distress (25). The PSSS consists of 12 items
that are scored on a 7-point Likert scale from (1  very strongly disagree) to (7 
very strongly agree). The scale yields three subscale scores for Family, Friends,
and Significant other, and a total score. For the purpose of the current study, we
only used the total score. A low score on the PSSS indicates low social support.
The psychometric properties of the scale are adequate with a test–retest reliability
of 0.85 and Cronbach’s   0.88 for the total scale (26).
Statistical Analyses
Discrete variables were compared with the chi-square test (Fisher’s Exact
test when appropriate) and continuous variables with Student’s t test for
independent samples. Logistic univariate and multivariate regression analyses
were performed to examine determinants of anxiety and depression (using a
cut-off of 8) in patients and partners. For patients in adjusted analyses,
gender, age, use of psychotropic medication, shocks, Type D personality, the
interaction term Type D  shocks, and social support were selected a priori
and retained in the model without regard to statistical significance together
with all clinical variables significant at p  .05. For partners in adjusted
analyses, gender, age, use of psychotropic medication, Type D personality,
and social support were selected a priori and entered in the model without
regard to statistical significance. All tests used were two-tailed. p  .05 was
used for all tests to indicate statistical significance. All statistical analyses
were performed using SPSS 11.5 for Windows.
RESULTS
Patient and partner characteristics are presented in Table 1.
Prevalence of Anxiety and Depressive Symptoms
Symptoms of anxiety were significantly more prevalent in
partners than in patients (42% vs. 31%; p  .048), whereas
TABLE 1. Sociodemographic and Clinical Characteristics of Patients and Partners
Patients (n  182) Partners (n  144)
n (%) Mean (SD) n (%) Mean (SD)
Females 35 (19) 125 (87)
Age 62 (13) 60 (12)
Education
University or equivalent 8 (4) 7 (5)
College 56 (31) 35 (24)
High school/A-levels 64 (35) 57 (40)
Basic education (up to grade 6) 47 (26) 44 (30)
Not known 7 (4) 1 (1)
Working 26 (14) 61 (42)
Using psychotropic medication 47 (26) 28 (20)
Coronary artery disease 131 (72) —
Chronic heart failure 44 (24) —
Previous myocardial infarction 110 (60) —
Previous cardiac arrest 89 (49) —
Previous bypass surgery 51 (28) —
Antiarrhythmic drug therapy at baseline 130 (72) —
Time since ICD implantation (months) 55 (35) —
Shocks received since implantationa
1 shock 14 (8) —
1 shock 41 (23) —
a As read by the data stored by the ICD.
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depressive symptoms were equally prevalent in patients and
their partners (28% vs. 29%; p  .901).
Group Differences on Anxiety and Depression
When stratifying by gender and patient status, a statistically
significant difference was found between groups on symptoms
of anxiety (p  .040) (Figure 1). Since the prevalence of
anxiety was higher in male partners, we undertook a further
comparison of male partners vs. a pooled group of male
patients, female patients, and female partners. Male partners
had significantly more symptoms of anxiety than the pooled
group (p  .036). No statistically significant differences were
found between groups on depressive symptoms (p  .99)
(Figure 1). Patients who had experienced 1 shock were more
likely to be anxious than patients who had experienced no
shock (p  .005). No differences were found between the
shock vs. no-shock patients on depressive symptoms (p 
.160). Patients using psychotropic medication were more
likely to suffer from anxiety (p  .001) and depressive symp-
toms (p  .001) than patients using no medication. Similar
results were found for partners using psychotropic medication
vs. partners using no medication (anxiety: p  .01; depres-
sion: p  .003). We found no statistical significant difference
between patients and partners on perceived social support
(p  .761).
Patients and partners with the Type D personality were
more likely to suffer from symptoms of anxiety than their
non-Type D counterparts (Figure 2). Similarly, Type D patient
and partners were more likely to suffer from depressive symp-
toms than their non-Type D counterparts (Figure 2). When
stratifying patients by personality type and shocks, anxiety
and depressive symptoms were more prevalent in Type D
patients with and without shocks compared with non-Type D
patients with and without shocks (Figure 3).
Determinants of Anxiety and Depressive Symptoms
in Patients
Shocks received since implantation (OR: 2.58; 95% CI:
1.32–5.03), Type D personality (OR: 8.25; 95% CI: 3.91–
17.40), and use of psychotropic medication (OR: 9.36; 95%
CI: 4.37–19.66) were related to an increased risk of anxiety in
patients in univariate analyses. No other clinical or psycho- logical variables were significant. In multivariate analyses,
Type D personality (OR: 7.03; 95% CI: 2.32–21.32), use of
psychotropic medication (OR: 8.16; 95% CI: 3.25–20.48), and
lack of social support (OR: 0.97; 95% CI: 0.95–0.99) were
independent determinants of symptoms of anxiety, adjusting
for all other factors including the interaction term Type D
personality  shocks. No other statistically significant deter-
minants were found, although there was a trend for shocks
(p  .06).
Type D personality (OR: 8.44; 95% CI: 3.98–17.93) and
use of psychotropic medication (OR: 5.16; 95% CI: 2.50–
10.64) were also related to a higher risk of depressive symp-
toms in patients in univariate analyses. Neither any of the
clinical variables nor social support was associated with de-
pressive symptoms. When adjusting for gender, age, experi-
Figure 1. Prevalence of anxiety and depression in ICD patients and their
partners stratified by gender
Figure 2. Prevalence of anxiety and depression in ICD patients and their
partners stratified by Type D personality. Number of patients/partners is given
at top of bars. A score on the Type D personality scale could not be calculated
for 1 patient and 1 partner.
Figure 3. Prevalence of anxiety and depression in ICD patients stratified by
Type D personality and shocks (no shocks vs. 1 shock)
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enced shocks, the interaction term Type D  shocks, and
social support, Type D personality (OR: 7.40; 95% CI: 2.49–
21.94) and use of psychotropic medication (OR: 4.00; 95%
CI: 1.65–9.67) remained significant determinants of depres-
sive symptoms.
Determinants of Anxiety and Depressive Symptoms
in Partners
In partners, Type D personality (OR: 9.50; 95% CI: 3.77–
23.97) and low perceived social support (OR: 0.96; 95% CI:
0.94–0.99) were associated with an increased risk of anxiety
in univariate analyses. Type D personality (OR: 8.77; 95% CI:
3.19–24.14) remained an independent determinant of anxiety
correcting for gender, age, and the use of psychotropic med-
ication, whereas social support was no longer significant.
Type D personality (OR: 4.64; 95% CI: 2.06–10.47) and
low social support (OR: 0.96; 95% CI: 0.94–0.98) were also
related to depressive symptoms in partners. Adjusting for
gender, age, psychotropic medication, and social support,
Type D (OR: 4.40; 95% CI: 1.76–11.01) was still associated
with increased levels of depression in partners. Although low
social support (OR: 0.97; 95% CI: 0.95–0.99) was also sig-
nificantly related to increased levels of depressive symptoms,
this increased risk may not be clinically relevant.
DISCUSSION
In the current study, the prevalence of anxiety was signif-
icantly higher in partners of ICD patients than in the ICD
patients, whereas the prevalence of depressive symptoms was
similar in the two groups. Stratification by gender and patient
status showed that anxiety was particularly prevalent in male
partners. Type D personality was identified as a significant
independent determinant of anxiety and depressive symptoms
in both patients and partners.
The prevalence of anxiety and depression in ICD patients
was consistent with that found in other studies (3,6). However,
levels of anxiety were significantly higher in partners than in
ICD patients. This corroborates results of earlier and relatively
smaller studies that partners may experience similar levels of
distress as ICD patients (10,18). It is particularly noteworthy
that male partners of ICD patients had comparatively higher
levels of anxiety compared with all other groups. Male part-
ners may be less used to discussing their feelings with others
and as a result have less recourse for sharing their emotions
compared with female partners, which in turn may result in
manifest anxiety. In general, men may also be more helpless
without their partner than women. Alternatively, females may
be more likely to use psychotropic medication to alleviate
their anxiety, although subsequent analyses showed no statis-
tically significant differences between male (11%) and female
partner (21%) use of medication. Except for De Groot and
colleagues (11), to our knowledge nobody has looked at
differences in distress according to gender and patient status in
an ICD population. Although De Groot and colleagues found
no significant difference in anxiety between male and female
partners, 25% male vs. 11% female partners suffered from
anxiety (11). In the current study, 58% male vs. 39% female
partners suffered from anxiety. Since male partners made up a
relatively small proportion of the total sample in both studies
(De Groot et al: n  25; current study: n  19), these results
should be interpreted with caution. Nevertheless, future re-
search should not overlook the possibility that there may be
female/male ICD patient/partner differences in distress, as
distress in subgroups of patients or partners may otherwise
remain unidentified and untreated.
Type D personality was a significant independent determi-
nant of anxiety and depressive symptoms in both patients and
partners. This finding is consistent with previous studies
showing that cardiac patients with the Type D personality
experience increased emotional and social difficulties that
may in the end lead to hard medical outcomes (12–14). Of
note, in ICD patients Type D personality was associated with
a seven-fold increased risk of anxiety, adjusting for all other
factors including shocks. In a prospective study, Dunbar and
colleagues found that anxiety was a precipitant of shocks, but
shocks were not associated with increased anxiety at fol-
low-up (7). By contrast, in the Antiarrhythmics Versus Im-
plantable Defibrillators (AVID) trial and the Canadian Im-
plantable Defibrillator Study (CIDS) shocks were related to
more psychological distress and impaired quality of life
(5,27). However, the CIDS trial showed that there may be a
dose–response relationship between shocks and distress as
only patients who had received 5 shocks were at risk of
adverse outcome (27). The fact that we used the categorization
none vs. 1 shock may in part explain why shocks were not
related to increased anxiety in the current study. Alternatively,
other factors, such as, for example, personality, may be a more
important determinant of distress than shocks with the caveat
in mind that our results are based on cross-sectional data. A
recent meta-analysis also challenges the belief that all distress
relates to shocks, but it was performed before the AVID and
CIDS trials and is based on studies with relatively small
sample sizes (28). Nevertheless, it may be time to expand our
focus beyond looking at only shocks as a potential determi-
nant of distress.
We also found that the buffering effect of social support on
anxiety and depressive symptoms in ICD patients, and on
anxiety in partners, was mediated by Type D personality. In a
recent study of patients with MI, the personality trait of
neuroticism was also found to mediate the effects of social
support on psychological distress and health complaints (16).
In other words, the underlying personality disposition of an
ICD patient and their partner may be more important in
determining levels of distress than perceived social support.
Except for ICD shocks, we found no relationships between
any of the other clinical variables and psychological distress in
patients, which suggests that differences in distress cannot be
accounted for by underlying cardiac pathology. This is counter
to the results of De Groot and colleagues, who found previous
MI, lower left ventricular ejection fraction (LVEF), and higher
NYHA functional class to be associated with increased dis-
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tress (10). However, in the current study, we had no informa-
tion on LVEF and NYHA class.
This study has a number of limitations. First, the cross-
sectional nature of the design does not allow for the determi-
nation of cause and effect. Hence, we cannot deduce whether,
for example, the use of psychotropic medication leads to
increased distress or vice versa, although it seems more likely
that increased distress will lead to reliance on psychotropic
medication than the other way around. Second, we had no
information on previous psychiatric history and the use of
psychotropic medication in both patients and partners before
implantation. Therefore, we do not know whether the use of
psychotropic medication is related to the ICD implantation or
some other life-event. Third, assessment of psychological
distress was based on a self-report measure, although the
sensitivity and specificity of this measure has proven ade-
quate. Fourth, no corrections were made for multiple compar-
isons in the statistical analyses. Despite these limitations,
compared with existing studies this study is based on a rela-
tively large sample of ICD patients and their partners, the
response rate is relatively high with 82%, and it is the first to
demonstrate that Type D personality may be of value not only
in CAD but also in arrhythmia research.
In conclusion, the results of the current study indicate that
partners are at equal risk of suffering from psychological
distress as ICD patients and that personality may be an im-
portant explanatory factor of distress in both ICD patients and
their partners. These results have implications for clinical
research and practice. Future prospective studies investigating
psychological adjustment after ICD implantation should not
only focus on ICD patients but also their partners, as this may
provide us with some indications as to whether psychosocial
programs should be extended to this group. Moreover, the role
of personality in determining distress in both ICD patients and
their partners should not be overlooked. In patients with CAD,
Type D personality has been associated with adverse clinical
outcome (12–14) and increased emotional and social difficul-
ties (15). See Pedersen and Denollet for a comprehensive
review (15). In the current study, we were able to show that
Type D also may be of value in arrhythmia research, although
studies are warranted to investigate the implications of this
finding for the clinical course of ICD patients. However, is
further research into a construct that is considered stable and
therefore not amenable to change at all useful? Just because
personality traits or the combination of traits, such as Type D,
are considered to exert a stable effect on behavior, this does
not imply that the levels of distress of Type D patients cannot
be reduced (29). A recent preliminary randomized controlled
trial has shown that comprehensive cardiac rehabilitation
comprising exercise, education, and a behavioral cognitive
intervention is safe for ICD patients, and leads to a reduction
in psychological distress and improved exercise ability com-
pared with usual care (30). A similar intervention could prove
successful in reducing the distress of ICD patients and part-
ners with a Type D personality.
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